Alzheimer sufferer - vertaling naar nederlands
Online Woordenboek

Alzheimer sufferer - vertaling naar nederlands

Alzheimer, Alois
  • Alzheimer's grave in Frankfurt

Alzheimer sufferer      
alzheimer disease         
  • 376–1266}}
  • A normal brain on the left and a late-stage Alzheimer's brain on the right
  • Stages of [[atrophy]] in Alzheimer's
  • Alois Alzheimer's patient [[Auguste Deter]] in 1902. Hers was the first described case of what became known as Alzheimer's disease.
  • Three-dimensional [[molecular model]] of [[donepezil]], an [[acetylcholinesterase inhibitor]] used in the treatment of Alzheimer's disease symptoms
  • granulovacuolar degeneration bodies]] (bottom center)
  • Intellectual activities such as playing [[chess]] or regular social interaction have been linked to a reduced risk of Alzheimer's disease in epidemiological studies, although no causal relationship has been found.
  • [[Cognitive test]]s such as the [[Mini–Mental State Examination]] (MMSE) can help in the diagnosis of Alzheimer's disease. In this test instructions are given to copy drawings like the one shown, remember some words, read, and subtract numbers serially.
  • Molecular structure of [[memantine]], a medication approved for advanced Alzheimer's disease symptoms
  • PET scan]] of the brain of a person with Alzheimer's disease showing a loss of function in the temporal lobe
  • In Alzheimer's disease, changes in tau protein lead to the disintegration of microtubules in brain cells.
Alzheimers disease; Alzheimer disease; Familial Alzheimer's disease; Alzheimer's; Alzheimer’s Disease; Alzheimer; Altimers; Alzheimers; Alzeihmers; Alzhiemer's disease; Alzheimer’s; DAT - Dementia Alzheimer's type; Alzhimer; Alzhemiers' disease; Alzhiemers; Alzheimer’s diseases; Alzheimer's Research; Alzheimer dementia; Oldtimer's disease; Old timers disease; Alzheimer's diseases; Alzheimer's disease research; Therapies under investigation for Alzheimer's disease; Clinical research to halt Alzheimer's disease & mild cognitve impairment; Alzeheimer's; Alzeheimers; Alstimers; Altzimers; Oldtimer disease; Old timer disease; Old timer's disease; Anti-dementia; Alzheimers Disease; Alzheimer's Disease; Oldtimers disease; Sdat; Alzheimer's dementia; Altzheimer; Alzheimer’s disease; Late-onset Alzheimer's Disease; Anti-dementia drug; Antidementia agent; Anti-dementia agent; Anti-dementia medication; Antidementia medication; Antialzheimer medication; Anti-alzheimer medication; Anti-Alzheimer medication; Anti-Alzheimer's medication; Anti-alzheimer's medication; Antialzheimer's medication; AntiAlzheimer's medication; AntiAlzheimer's drug; Antialzheimer's drug; AntiAlzheimer medication; Anti-alzheimer's drug; Anti-Alzheimer's drug; Anti-Alzheimer drug; AntiAlzheimer drug; Antialzheimer drug; Anti-alzheimer's agent; Antialzheimer's agent; AntiAlzheimer's agent; Anti-Alzheimer's agent; Anti-Alzheimer agent; AntiAlzheimer agent; Antialzheimer agent; Anti-alzheimer agent; Primary degenerative dementia of the Alzheimer's type; Senile dementia of the Alzheimer type; Old-timers' disease; Old-timer's disease; Alzheimer's Syndrome; Alzheimer's research directions; Alzheimer's disease clinical research; Alzheimer's disease and diet; User:Doyeon Koo/sandbox; User:Feliskoo/sandbox; Alzheimer's Disease and Diet; Gamma secretase inhibition; Antialzheimer; Retrogenesis; Alzeimers; Alzeimer's; Alzeimer's disease; Alzeimers disease; Retrogenesis theory; Aluminum Hypothesis; Aluminium hypothesis; Alzheimer's syndrome; Alzheimer's disease research in 2016; 2016 in Alzheimer; Alzeheimer's Disease; Signs and symptoms of Alzheimer's Disease; Causes of Alzheimer's disease; Alzheimers research; Treatment of Alzheimer's disease; Prevention of Alzheimer's disease; Genetic risk factors for Alzheimer's disease; Genetic causes of Alzheimer's disease; Genetics of Alzheimer's disease; Social impact of Alzheimer's disease; Nonfamilial Alzheimer's disease; Sporadic Alzheimer's disease; Management of Alzheimer's disease; Old-timers disease
n. degeneratieve ziekte van het centrale zenuwstelsel gekenmerkt door dementie (hoofdzakelijk bij bejaarden)




Alois Alzheimer

Alois Alzheimer ( ALTS-hy-mər, US also AHLTS-, AWLTS-, German: [ˈaːlɔɪs ˈʔaltshaɪmɐ]; 14 June 1864 – 19 December 1915) was a German psychiatrist and neuropathologist and a colleague of Emil Kraepelin. Alzheimer is credited with identifying the first published case of "presenile dementia", which Kraepelin would later identify as Alzheimer's disease.